11.49

2.13% -0.25

CorMedix Inc (CRMD)

Overview News Price History Option Chain Discussions Forecast Stock Split

CorMedix Inc stock is traded at $11.49, with a volume of 3.55M. It is down -2.13% in the last 24 hours and up +0.61% over the past month. CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.

Previous Close:

$11.74

Open:

$11.91

24h Volume:

3.55M

Relative Volume:

1.27

Market Cap:

$905.29M

Revenue:

$65,400

Net Income/Loss:

$-46.34M

P/E Ratio:

-12.49

EPS:

-0.92

Net Cash Flow:

$-38.74M

1W Performance:

+8.81%

1M Performance:

+0.61%

6M Performance:

-22.68%

1Y Performance:

+31.01%

1-Day Range:

$11.49

$11.91

1-Week Range:

$10.65

$12.10

52-Week Range:

$5.60

$17.43

CorMedix Inc Stock (CRMD) Company Profile

Name

CorMedix Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

908-517-9500

Address

400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ

Employee

Twitter

Next Earnings Date

2025-03-25

Latest SEC Filings

CRMD's Discussions on Twitter

Compare CRMD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRMD CorMedix Inc	11.49	924.98M	65,400	-46.34M	-38.74M	-0.92
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Upgrade	D. Boral Capital	Hold → Buy
Jun-30-25	Downgrade	D. Boral Capital	Buy → Hold
Jun-30-25	Initiated	H.C. Wainwright	Buy
Mar-07-25	Initiated	Leerink Partners	Outperform
Jan-13-25	Initiated	D. Boral Capital	Buy
Aug-26-24	Initiated	Rodman & Renshaw	Buy
Aug-10-23	Initiated	RBC Capital Mkts	Outperform
Feb-17-21	Initiated	Needham	Buy
Sep-29-20	Initiated	JMP Securities	Mkt Outperform
Sep-21-20	Initiated	Truist	Buy
Dec-18-19	Initiated	B. Riley FBR	Buy
Mar-26-19	Reiterated	H.C. Wainwright	Buy
Dec-06-18	Initiated	ROTH Capital	Buy
Sep-25-17	Reiterated	H.C. Wainwright	Buy
Aug-10-17	Reiterated	Rodman & Renshaw	Buy
May-05-17	Reiterated	Rodman & Renshaw	Buy
Nov-11-16	Reiterated	FBR & Co.	Outperform
Mar-17-16	Reiterated	FBR Capital	Outperform
Mar-03-16	Initiated	FBR Capital	Outperform
Nov-16-15	Reiterated	ROTH Capital	Neutral
Oct-29-15	Reiterated	ROTH Capital	Neutral
May-06-15	Downgrade	ROTH Capital	Buy → Neutral
Dec-08-14	Reiterated	ROTH Capital	Buy
Oct-03-11	Downgrade	Maxim Group	Buy → Hold

View All

CorMedix Inc Stock (CRMD) Latest News

Dec 11, 2025

Cormedix Director Makes a Significant Stock Sale! - TipRanks

Dec 11, 2025

Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance - MSN

Dec 11, 2025

CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock? - sharewise.com

Dec 11, 2025

CorMedix director Dillione sells $408,000 in stock By Investing.com - Investing.com South Africa

Dec 11, 2025

CorMedix director Dillione sells $408,000 in stock - Investing.com

Dec 11, 2025

Steven Lefkowitz Implements A Sell Strategy: Offloads $475K In Cormedix Stock - Benzinga

Dec 11, 2025

CorMedix Inc. Stock (CRMD) Opinions on Insider Selling and Growth Metrics - Quiver Quantitative

Dec 11, 2025

Lefkowitz Steven W, director at CorMedix, sells $475k in CRMD stock - Investing.com Canada

Dec 11, 2025

Dec 10, 2025

CorMedix (CRMD): Is the Market Mispricing This Underappreciated Anti-Infective Growth Story? - Yahoo Finance

Dec 10, 2025

Dec 09, 2025

Does CorMedix (CRMD) Have the Potential to Rally 68.74% as Wall Street Analysts Expect? - Finviz

Dec 09, 2025

Dec 08, 2025

CorMedix (CRMD) Upgraded to Strong Buy: Here's What You Should Know - sharewise.com

Dec 08, 2025

Best Value Stocks to Buy for December 8th - sharewise.com

Dec 08, 2025

New Strong Buy Stocks for December 8th - Zacks Investment Research

Dec 08, 2025

Dec 07, 2025

CorMedix Shares Garner Strong Analyst Confidence Following Robust Earnings - AD HOC NEWS

Dec 07, 2025

Dec 06, 2025

Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead? - sharewise.com

Dec 06, 2025

Dec 05, 2025

CorMedix director Dillione sells $466k in shares By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 04, 2025

Is CorMedix Stock Still Attractive After Strong Multi Year Gains And Recent Volatility In 2025 - Yahoo Finance

Dec 04, 2025

Deep Track Capital, LP's Strategic Acquisition of Cormedix Inc Shares - GuruFocus

Dec 03, 2025

Will CorMedix Inc. (19KA) stock benefit from sector leadershipBuy Signal & Reliable Volume Spike Trade Alerts - Newser

Dec 03, 2025

Is CorMedix Inc. stock supported by innovation pipelineQuarterly Profit Report & Risk Managed Investment Entry Signals - Newser

Dec 03, 2025

Will CorMedix Inc. (19KA) stock see insider accumulationLong Setup & Accurate Entry/Exit Alerts - Newser

Dec 03, 2025

Should I buy CorMedix Inc. (19KA) stock before earnings seasonJuly 2025 Earnings & Daily Stock Trend Reports - Newser

Dec 03, 2025

Dec 02, 2025

Can CorMedix Inc. stock sustain revenue growthWeekly Profit Summary & Consistent Return Investment Signals - Newser

Dec 02, 2025

Will CorMedix Inc. stock see PE expansionRate Cut & High Accuracy Trade Signal Alerts - Newser

Dec 02, 2025

Cormedix (CRMD) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

Is CorMedix Inc. stock a bargain at current levelsTrade Entry Report & Short-Term Trading Opportunity Alerts - Newser

Dec 02, 2025

Dec 01, 2025

Would You Still Hold Cormedix Stock If It Fell Another 30%? - Trefis

Dec 01, 2025

Nov 28, 2025

Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday - Sahm

Nov 28, 2025

Nov 27, 2025

CorMedix director Dillione sells $261,585 in CRMD stock By Investing.com - Investing.com Australia

Nov 27, 2025

At Cormedix, Janet Dillione Chooses To Exercise Options, Resulting In $158K - Benzinga

Nov 27, 2025

Nov 26, 2025

CorMedix director Dillione sells $261,585 in CRMD stock - Investing.com India

Nov 26, 2025

CorMedix Director Janet Dillione Sells 26,343 Shares - TradingView

Nov 26, 2025

Dir Dillione Sells 26,343 ($261.6K) Of CorMedix Inc [CRMD] - TradingView

Nov 26, 2025

CorMedix (CRMD) Is Down 6.3% After Strong Q3 Results and $87.6M Shelf Registration Filed - simplywall.st

Nov 26, 2025

Nov 24, 2025

What drives CorMedix Inc stock priceAnalyst Downgrades & Small Capital Trading Plans - earlytimes.in

Nov 24, 2025

Assessing CorMedix (CRMD): Is the Current Share Price Reflecting Its True Value? - Yahoo Finance

Nov 24, 2025

Dir Dillione Files To Sell 73,000 Of CorMedix Inc [CRMD] - TradingView

Nov 24, 2025

Nov 22, 2025

H.C. Wainwright Raises the PT on CorMedix Inc. (CRMD), Keeps a Buy - MSN

Nov 22, 2025

Nov 21, 2025

American Kidney Fund Hosts Third Patient Access Initiative Summit to Address Barriers to Kidney Care and Propose Innovative Solutions - GlobeNewswire Inc.

Nov 21, 2025

Will CorMedix Inc. (19KA) stock deliver compounding returns2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com

Nov 21, 2025

How institutional buying supports CorMedix Inc. stockJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com

Nov 21, 2025

Nov 20, 2025